148 related articles for article (PubMed ID: 27383192)
1. Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review.
Green G; Carmona R; Zakeri K; Lee CH; Borgan S; Marhoon Z; Sharabi A; Mell LK
PLoS One; 2016; 11(7):e0156489. PubMed ID: 27383192
[TBL] [Abstract][Full Text] [Related]
2. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
Saumet A; Lecellier CH
Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
[TBL] [Abstract][Full Text] [Related]
4. Emerging trends in biomarker discovery: Ease of prognosis and prediction in cancer.
Sharma AK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):iii-iv. PubMed ID: 29857038
[No Abstract] [Full Text] [Related]
5. Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review.
Savina M; Gourgou S; Italiano A; Dinart D; Rondeau V; Penel N; Mathoulin-Pelissier S; Bellera C
Crit Rev Oncol Hematol; 2018 Mar; 123():21-41. PubMed ID: 29482777
[TBL] [Abstract][Full Text] [Related]
6. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
[TBL] [Abstract][Full Text] [Related]
7. Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review.
Bibault JE; Fumagalli I; Ferté C; Chargari C; Soria JC; Deutsch E
Cancer Metastasis Rev; 2013 Dec; 32(3-4):479-92. PubMed ID: 23595306
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.
Qi XW; Zhang F; Wu H; Liu JL; Zong BG; Xu C; Jiang J
Sci Rep; 2015 Mar; 5():8924. PubMed ID: 25748047
[TBL] [Abstract][Full Text] [Related]
9. Endpoints in cancer clinical trials.
Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
[TBL] [Abstract][Full Text] [Related]
10. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
Kamel HFM; Al-Amodi HSAB
Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic biomarkers for personalized cancer treatment.
Rodríguez-Antona C; Taron M
J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
[TBL] [Abstract][Full Text] [Related]
12. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
[TBL] [Abstract][Full Text] [Related]
14. Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.
Xu T; Jin Z; Yuan Y; Zheng H; Li C; Hou W; Guo Q; Hua B
PLoS One; 2016; 11(12):e0168408. PubMed ID: 28036326
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the physiological reserves of older patients with cancer: the value of potential biomarkers of aging?
Pallis AG; Hatse S; Brouwers B; Pawelec G; Falandry C; Wedding U; Lago LD; Repetto L; Ring A; Wildiers H
J Geriatr Oncol; 2014 Apr; 5(2):204-18. PubMed ID: 24495695
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of cancer cachexia.
Loumaye A; Thissen JP
Clin Biochem; 2017 Dec; 50(18):1281-1288. PubMed ID: 28739222
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers are hot.
Gullans SR
Biotechniques; 2005 Apr; Suppl():7. PubMed ID: 16528917
[No Abstract] [Full Text] [Related]
18. Considerations for Implementation of Cancer Molecular Diagnostics Into Clinical Care.
Hayes DF
Am Soc Clin Oncol Educ Book; 2016; 35():292-6. PubMed ID: 27249708
[TBL] [Abstract][Full Text] [Related]
19. Predictive and prognostic cancer biomarkers revisited.
Pritzker KP
Expert Rev Mol Diagn; 2015; 15(8):971-4. PubMed ID: 26134385
[TBL] [Abstract][Full Text] [Related]
20. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
Mansoori B; Mohammadi A; Shirjang S; Baradaran B
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
